Naglazyme, Konzentrat zur Herstellung einer Infusionslösung
7680582240013
CH-58224
Konzentrat
Associated product:
NAGLAZYME conc perf 5 mg/5ml flac 5 ml
1 / 3
google
Article details
- Package size
- 1 x 5 ml
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
18.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1462.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2025
Authorization holder
DRAC AG
3280 Murten
Authorization information
- Swissmedic authorization number
- 58224
- Drug name
- Naglazyme, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- A16AB08
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 02/10/2007
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.14.0.
- Domain
- Human medicine
Package details
- Description (FR)
- NAGLAZYME conc perf 5 mg/5ml flac 5 ml
- Description (DE)
- NAGLAZYME Inf Konz 5 mg/5ml Durchstf 5 ml
- Market launch
- 02/10/2007
- Narcotic (BTM)
- No